Recalculation of warrants in series TO5

Due to the issuance of new shares in the rights issue announced on November 18, 2019, Brighter AB (publ) ("Brighter") has, in accordance with the terms and conditions of the TO5 Brighter warrants, carried out a recalculation of the TO5 warrants.

Changes have been made to both the subscription price of the warrants and the number of Brighter shares that each warrant entitle subscription for. Information on the recalculated terms is shown below:

Warrants Series TO5

The subscription price in the TO5 series is, after recalculation, SEK 6.40 per share. Prior to the recalculation, the subscription price was SEK 10.56 per share.

The number of Brighter shares that each warrant in the TO5 series entitles subscription for after the recalculation, is 1.65. Prior to the recalculation, 1 warrant entitled subscription of 1 share.

The remaining subscription periods in series TO5 are

  • 22 May – 5 June, 2020
  • 20 November – 4 December, 2020
  • 21 May – June 4, 2021
  • 22 November – 6 December, 2021
  • 23 May – 6 June, 2022
  • 21 November – 5 December, 2022
  • 23 May – 5 June, 2023

Complete terms
Complete terms for warrant series TO3, TO4 and TO5 can be found on Brighter's website, https://brighter.se/investors/financing-home/warrants.

For further information, please contact:

Ann Zetterberg, CFO
Phone: +46 708 37 21 23
Email: ann.zetterberg@brighter.se

Henrik Norström, CEO
Phone: +46 733 40 30 45
Email: henrik.norstrom@brighter.se

About Brighter AB (publ)
Brighter is a health-tech company from Sweden with a vision of a world where managing chronic diseases is no longer a struggle. We believe a data-centric approach is key to provide smarter care for chronic conditions. Our daily-care solutions facilitate the flow of real-life treatment data between chronic-disease patients, their loved ones and their care providers – improving quality of life, easing the burden on healthcare systems, and opening new opportunities for data-driven research. Brighter is certified under ISO 13485. In 2019 the company won the Swecare Rising Stars Award. https://brighter.se/

The Company's shares are listed on Nasdaq First North Growth Market/BRIG. Brighter’s Certified Adviser is Eminova Fondkommission AB, +46 (0)8 – 684 211 10, adviser@eminova.se, www.eminova.se.

About Us

Brighter is a Swedish health-tech company with a vision of a world where managing chronic diseases is no longer a struggle. We believe a data-centric approach is key to provide smarter care for chronic conditions. Our daily-care solutions facilitate the flow of real-life treatment data between chronic-disease patients, their loved ones and their care providers – improving quality of life, easing the burden on healthcare systems, and opening new opportunities for data-driven research. Brighter is certified under ISO 13485. In 2019 the company won the Swecare Rising Stars Award. https://brighter.se/ The Company's shares are listed on Nasdaq First North Growth Market/BRIG. Brighter’s Certified Adviser is Eminova Fondkommission AB +46 (0)8 – 684 211 10, adviser@eminova.se, www.eminova.se

Subscribe

Documents & Links